Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Canopy Growth Corporation (CGC) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, along with AI-powered summaries that help interpret complex documents. As a Canadian issuer with common shares listed on the Nasdaq Global Select Market, Canopy Growth files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy materials with the U.S. Securities and Exchange Commission.
Current reports on Form 8-K are central to understanding material events affecting CGC stock. Recent 8-K filings describe items such as the arrangement agreement to acquire MTL Cannabis Corp., including consideration structure, conditions, and termination provisions; term loan amendments and prepayment agreements; at-the-market equity distribution arrangements; quarterly earnings releases furnished under Item 2.02; and changes in executive leadership, including the appointment of the Chief Financial Officer. Other 8-Ks report on shareholder meeting results, including director elections, auditor re-appointment, share consolidation authority, and advisory say-on-pay votes.
Periodic reports—the Form 10-K and Form 10-Q—contain detailed financial statements, segment information for cannabis and Storz & Bickel, risk factors related to the cannabis industry and regulatory environment, management’s discussion and analysis, and disclosures on liquidity, capital resources, and internal controls. These filings also incorporate risk discussions referenced in the company’s news releases, including legal and regulatory risks in Canada, Europe, Australia, and the United States.
Proxy statements on Schedule 14A outline Canopy Growth’s corporate governance framework, board composition, committee structures, and executive compensation programs. They describe director nominees, voting matters presented at the annual general and special meeting, and updates to governance policies such as the code of business conduct and ethics, disclosure policy, and insider trading policy.
On this page, Stock Titan’s tools surface new CGC filings as they appear on EDGAR and generate AI summaries that highlight key terms, covenants, and implications for shareholders. Users can quickly see the main points of a lengthy 10-K, review the core provisions of financing or acquisition agreements disclosed in 8-Ks, and identify how shareholder votes and governance changes may affect the company. Filings related to insider compensation and board decisions are also accessible through these documents.
Canopy Growth Corp (CGC) director Willy Kruh reported the sale of 10,451 common shares on 09/29/2025 at $1.58 per share, leaving him with 62,939 shares beneficially owned. The Form 4 states the shares sold were previously granted as restricted stock units on June 3, 2025, and the sale was made to satisfy tax obligations arising from vesting. The filing is signed by an attorney-in-fact on behalf of the reporting person on 09/30/2025. The report is a single-person Form 4 disclosure and identifies the reporting person as a director.
Canopy Growth Corp director and Chief Executive Officer Luc Mongeau (reporting person) acquired 27,469 common shares on 09/22/2025 at a price of CA$1.82 per share, as reported on Form 4. Following the transaction, Mongeau beneficially owned 812,368 common shares. The Form 4 was signed by an attorney-in-fact on behalf of Mongeau on 09/23/2025. The filing notes that the price is expressed in Canadian dollars. No derivative transactions or additional details were reported.
Stewart Thomas Carlton, serving as Chief Financial Officer and Chief Accounting Officer of Canopy Growth Corp (CGC), reported equity awards granted on 09/17/2025. He received 178,462 restricted stock units (RSUs) that vest in three equal annual installments, and was granted 222,280 stock options$1.40 that vest in three equal annual installments and expire on 09/17/2031. After the reported transactions, the filing shows 246,665 common shares beneficially owned by the reporting person. The form reflects standard compensation awards for executive retention and alignment with shareholders.
Canopy Growth Corp filed an Form 8-K reporting an employment agreement effective September 17, 2025 between Canopy Growth USA, LLC and Thomas Stewart. The filing references standard 8-K items including departures/elections or appointments of officers or directors, Regulation FD disclosure, and financial statements and exhibits. The exhibits listed include the Employment Agreement, a Press Release dated September 17, 2025, and an embedded Inline XBRL cover page data file. The document is signed by Christelle Gedeon, Chief Legal Officer.
Canopy Growth Corporation filed an Form 8-K reporting Regulation FD disclosure and other events. The filing lists an Equity Distribution Agreement dated August 29, 2025 with BMO Capital Markets Corp. and BMO Nesbitt Burns Inc., legal opinion and consent from Cassels Brock & Blackwell LLP, and a press release dated August 29, 2025. The company also references an Interactive Data File (Inline XBRL) and notes that one non-material exhibit was omitted under Item 601(a)(5) of Regulation S-K, with supplemental copies available on request to the SEC.
The document is primarily an exhibits and disclosure notice; it does not include financial tables, earnings figures, or details of the equity distribution terms within the text provided here.
Canopy Growth filed a prospectus supplement for an "at the market" equity offering to sell up to $200,000,000 of common shares, with concurrent sales in Canada limited to $50,000,000 (the Canadian Cap). Sales will be effected through an Equity Distribution Agreement with BMO Capital Markets Corp. (U.S. Agent) and BMO Nesbitt Burns Inc. (Canadian Agent) for up to 3% commission. The company’s shares trade on the TSX under "WEED" and Nasdaq under "CGC"; the last reported Nasdaq sale price on August 28, 2025 was $1.88 per share. The prospectus states proceeds will be used for investments, potential acquisitions, working capital and possible repayment of indebtedness, including amounts outstanding under a secured first lien term loan facility (Credit Facility) with a current principal of $125.6 million and required prepayments of $10 million by December 31, 2025 and $15 million by March 31, 2026. The filing discloses potential dilution, lists outstanding share and convertible instruments counts, and highlights U.S. tax risks including possible PFIC classification.
Stewart Thomas Carlton, identified as an Officer with the remark Interim Chief Financial Officer, reported a sale of common shares of Canopy Growth Corp (CGC). On 08/22/2025 he disposed of 5,768 common shares at a price of CAD 1.74 per share; the filing states the sale was in part to satisfy tax obligations tied to the vesting of restricted stock units. After the reported transaction, he beneficially owned 68,203 common shares. The Form 4 was signed by an attorney-in-fact, Shai Marshall, on 08/26/2025. This filing discloses an insider share disposition linked to compensation tax settlement rather than an open-market purchase.
Canopy Growth Corp director and Chief Legal Officer & Corporate Secretary Christelle Gedeon reported a sale of 16,929 common shares on 08/22/2025 at a price of CAD $1.74 per share. The filing states the disposition was made to satisfy tax obligations tied to the vesting of restricted stock units. After the sale, the reporting person beneficially owned 368,488 common shares. The Form 4 was signed by an attorney-in-fact on 08/26/2025. All amounts and the sale rationale are presented in the filing; no additional transaction types or derivative holdings are disclosed.
Christelle Gedeon, Chief Legal Officer and Corporate Secretary of Canopy Growth Corp (CGC), reported a sale of 4,528 common shares on 08/18/2025 at a price of CA$1.86 per share. The filing shows 385,417 shares beneficially owned by Ms. Gedeon after the transaction. The form states the disposition was made to satisfy tax obligations arising from the vesting of restricted stock units. The report was signed by an attorney-in-fact on behalf of the reporting person and is a routine officer disclosure under Section 16.
Canopy Growth Corp (CGC) reported a grant of 45,680 restricted stock units to director M. Shan Atkins on August 12, 2025. The RSUs were issued as compensation and will vest in three scheduled tranches: 10,578 RSUs on September 29, 2025, 17,551 RSUs on December 31, 2025, and 17,551 RSUs on March 31, 2026. The filing shows the reporting person is a director and the transaction was reported as an acquisition at no cash price. The Form 4 was signed by an attorney-in-fact on August 14, 2025, and provides the standard disclosure of beneficial ownership following the grant.